Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
Authors
Keywords
-
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 235, Issue -, Pages 108121
Publisher
Elsevier BV
Online
2022-02-02
DOI
10.1016/j.pharmthera.2022.108121
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AT-527, a double prodrug of a guanosine nucleotide analog, is a potent inhibitor of SARS-CoV-2 in vitro and a promising oral antiviral for treatment of COVID-19
- (2021) Steven S. Good et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series
- (2021) Julu Bhatnagar et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2 causes severe epithelial inflammation and barrier dysfunction
- (2021) Stefanie Deinhardt-Emmer et al. JOURNAL OF VIROLOGY
- SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
- (2021) Angela Wahl et al. NATURE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome
- (2021) Koichiro Suemori et al. PLoS Neglected Tropical Diseases
- Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
- (2021) Andrew Rambaut et al. Nature Microbiology
- Rapid endotheliitis and vascular damage characterize SARS‐CoV‐2 infection in a human lung‐chip model
- (2021) Vivek V Thacker et al. EMBO REPORTS
- Early favipiravir treatment was associated with early defervescence in non-severe COVID-19 patients
- (2021) Satoshi Fujii et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- β-D-N 4-hydroxycytidine (NHC) Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
- (2021) Shuntai Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccine Breakthrough Infections with SARS-CoV-2 Variants
- (2021) Ezgi Hacisuleyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
- (2021) Kyle Rosenke et al. Nature Communications
- The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways
- (2021) Manon Laporte et al. PLoS Pathogens
- Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
- (2021) Hirofumi Ohashi et al. iScience
- Improvement of acyclovir‐resistant herpes zoster infection by amenamevir
- (2021) Takashi Onaka et al. JOURNAL OF DERMATOLOGY
- Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
- (2021) Nir Drayman et al. SCIENCE
- The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
- (2021) Soheil Hassanipour et al. Scientific Reports
- Favipiravir-resistant influenza A virus shows potential for transmission
- (2021) Daniel H. Goldhill et al. PLoS Pathogens
- Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial
- (2021) Masaharu Shinkai et al. Infectious Diseases and Therapy
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
- (2020) Kimiyasu Shiraki et al. PHARMACOLOGY & THERAPEUTICS
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19
- (2020) Jerome R. Lechien et al. ANNALS OF INTERNAL MEDICINE
- Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults
- (2020) Supinda Bunyavanich et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS-CoV-2: a storm is raging
- (2020) Savannah F. Pedersen et al. JOURNAL OF CLINICAL INVESTIGATION
- An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
- (2020) Lucio Verdoni et al. LANCET
- Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study
- (2020) Qifang Bi et al. LANCET INFECTIOUS DISEASES
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiorgan and Renal Tropism of SARS-CoV-2
- (2020) Victor G. Puelles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of COVID-19 Among Children in China
- (2020) Yuanyuan Dong et al. PEDIATRICS
- Children's mortality from COVID-19 compared with all-deaths and other relevant causes of death: epidemiological information for decision-making by parents, teachers, clinicians and policymakers
- (2020) Sunil Bhopal et al. PUBLIC HEALTH
- The mystery of the pandemic's ‘happy hypoxia’
- (2020) Jennifer Couzin-Frankel SCIENCE
- SARS-CoV-2 (COVID-19) by the numbers
- (2020) Yinon M Bar-On et al. eLife
- Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset
- (2020) Hao-Yuan Cheng et al. JAMA Internal Medicine
- Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019
- (2020) Adeel S. Zubair et al. JAMA Neurology
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
- (2020) Ling Mao et al. JAMA Neurology
- Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020
- (2020) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020
- (2020) Wycliffe E. Wei et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Potential Effects of Coronaviruses on the Cardiovascular System
- (2020) Mohammad Madjid et al. JAMA Cardiology
- Why COVID-19 Silent Hypoxemia Is Baffling to Physicians
- (2020) Martin J. Tobin et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- COVID‐19 and kidney transplantation: Results from the TANGO International Transplant Consortium
- (2020) Paolo Cravedi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir
- (2020) Kimiyasu Shiraki et al. ANTIVIRAL RESEARCH
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
- (2020) Andrey A Ivashchenko et al. CLINICAL INFECTIOUS DISEASES
- Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis
- (2020) Sakiko Tabata et al. LANCET INFECTIOUS DISEASES
- Neurological associations of COVID-19
- (2020) Mark A Ellul et al. LANCET NEUROLOGY
- Immunological and inflammatory profiles in mild and severe cases of COVID-19
- (2020) Jin-Wen Song et al. Nature Communications
- Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza
- (2020) Alexander E. Merkler et al. JAMA Neurology
- Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020
- (2020) Erin K. Stokes et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
- (2020) Andrew Rambaut et al. Nature Microbiology
- In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
- (2020) Andrés Pizzorno et al. ANTIVIRAL RESEARCH
- Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques
- (2020) Malika Aid et al. CELL
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and cardiac characteristics of COVID‐19 mortalities in a diverse New York City Cohort
- (2020) Mark P. Abrams et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- CKD is a key risk factor for COVID-19 mortality
- (2020) Ron T. Gansevoort et al. Nature Reviews Nephrology
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings
- (2020) Phoebe C.M. Williams et al. PATHOLOGY
- Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
- (2020) Suzanne J. F. Kaptein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
- (2020) Ashleigh Shannon et al. Nature Communications
- Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults
- (2020) Russell M. Viner et al. JAMA Pediatrics
- Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients
- (2020) Eric M. Liotta et al. Annals of Clinical and Translational Neurology
- Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
- (2020) Sean X. Gu et al. Nature Reviews Cardiology
- Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
- (2020) Robert M. Cox et al. Nature Microbiology
- Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
- (2019) Per Ljungman et al. LANCET INFECTIOUS DISEASES
- Role of the Innate Cytokine Storm Induced by the Influenza A Virus
- (2019) Yinuo Gu et al. VIRAL IMMUNOLOGY
- A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection
- (2019) Candice Poux et al. Frontiers in Immunology
- The Expression of miRNAs in Human Ovaries, Oocytes, Extracellular Vesicles, and Early Embryos: A Systematic Review
- (2019) Albert Salas-Huetos et al. Cells
- Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
- (2018) Leen Delang et al. ANTIVIRAL RESEARCH
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
- (2018) Frederick G. Hayden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation Sequencing
- (2018) Daniel H. Goldhill et al. JOURNAL OF VIROLOGY
- The mechanism of resistance to favipiravir in influenza
- (2018) Daniel H. Goldhill et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 2017 European guidelines for the management of genital herpes
- (2017) Rajul Patel et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study
- (2017) Makoto Kawashima et al. JOURNAL OF DERMATOLOGY
- Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion
- (2017) Yu Akahoshi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Characterization of susceptibility variants of poliovirus grown in the presence of favipiravir
- (2017) Tohru Daikoku et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis
- (2016) Evelien Vanderlinden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir
- (2016) Emi Takashita et al. ANTIVIRAL RESEARCH
- Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)—Sierra Leone, 2014
- (2016) Chang-Qing Bai et al. CLINICAL INFECTIOUS DISEASES
- Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy
- (2016) Tohru Daikoku et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- 2014 UK national guideline for the management of anogenital herpes
- (2015) Raj Patel et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers
- (2015) Michael Jacobs et al. LANCET INFECTIOUS DISEASES
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- (2014) Lisa Oestereich et al. ANTIVIRAL RESEARCH
- HIV Prevention in Clinical Care Settings
- (2014) Jeanne M. Marrazzo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral
- (2014) Leen Delang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of Susceptibility Variants of Influenza Virus Grown in the Presence of T-705
- (2014) Tohru Daikoku et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
- (2014) Roy F. Chemaly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Favipiravir elicits antiviral mutagenesis during virus replication in vivo
- (2014) Armando Arias et al. eLife
- Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
- (2013) Hidehiro Sangawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts
- (2013) M. J. Memoli et al. CLINICAL INFECTIOUS DISEASES
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
- (2013) T. Baranovich et al. JOURNAL OF VIROLOGY
- Telomere length and telomerase activity during oocyte maturation and early embryo development in mammalian species
- (2013) S. Ozturk et al. MOLECULAR HUMAN REPRODUCTION
- The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
- (2013) Zhinan Jin et al. PLoS One
- Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
- (2013) Everett Clinton Smith et al. PLoS Pathogens
- Protective Role of Toll-like Receptor 3-Induced Type I Interferon in Murine Coronavirus Infection of Macrophages
- (2012) Liudmila Mazaleuskaya et al. Viruses-Basel
- Infection of human alveolar macrophages by human coronavirus strain 229E
- (2011) C. J. Funk et al. JOURNAL OF GENERAL VIROLOGY
- Neutralizing Anti-gH Antibody of Varicella-Zoster Virus Modulates Distribution of gH and Induces Gene Regulation, Mimicking Latency
- (2011) K. Shiraki et al. JOURNAL OF VIROLOGY
- In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses
- (2010) K. Sleeman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy
- (2010) Harald Hofer et al. JOURNAL OF HEPATOLOGY
- Telomere lengths in human oocytes, cleavage stage embryos and blastocysts
- (2010) S. Turner et al. MOLECULAR HUMAN REPRODUCTION
- T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
- (2009) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials
- (2009) Tahany Awad et al. HEPATOLOGY
- An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
- (2009) Yoshiko Maida et al. NATURE
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge Studies
- (2008) Fabrice Carrat et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More